Dwight Moxie

Companies

• Revance Therapeutics, Inc.General counsel Mar 4, 2024 to Feb 6, 2025¹
• Revance Therapeutics, Inc.SVP, GC & Secretary Feb 19, 2020 to Feb 2, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRevance Therapeutics, Inc.0 shares³Feb 6, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 6, 2025Returned to company 18,125 shares of Revance Therapeutics, Inc.³
• Feb 6, 2025Granted 18,125 shares of Revance Therapeutics, Inc.³
• Feb 6, 2025Returned to company 95,979 shares of Revance Therapeutics, Inc.³
• Feb 4, 2025U 47,815 shares at $3.65 of Revance Therapeutics, Inc.³
• Feb 3, 2025Granted 5,979 shares of Revance Therapeutics, Inc.⁴
• Mar 18, 2024Sold 8,125 shares at $5.04 of Revance Therapeutics, Inc.⁵
• Mar 15, 2024Shares withheld for tax 3,269 shares at $5.31 of Revance Therapeutics, Inc.⁵
• Feb 29, 2024Granted 15,143 shares of Revance Therapeutics, Inc.⁶
• Jan 31, 2024Granted 90,000 shares of Revance Therapeutics, Inc.⁷
• Sep 6, 2023Sold 11,000 shares at $17.06 of Revance Therapeutics, Inc.⁸
• Sep 5, 2023Sold 23,853 shares at $17.81 of Revance Therapeutics, Inc.⁸
• Aug 11, 2023Shares withheld for tax 9,592 shares at $18.91 of Revance Therapeutics, Inc.⁹
• Aug 11, 2023Granted 19,346 shares of Revance Therapeutics, Inc.⁹
• May 15, 2023Sold 21,401 shares at $34.55 of Revance Therapeutics, Inc.¹⁰
• Mar 15, 2023Shares withheld for tax 7,330 shares at $30.65 of Revance Therapeutics, Inc.¹¹
• Mar 9, 2023Sold 18,496 shares at $31.59 of Revance Therapeutics, Inc.¹²
• Sep 22, 2022Granted 42,349 shares of Revance Therapeutics, Inc.¹²
• Sep 14, 2022Sold 11,000 shares at $27.07 of Revance Therapeutics, Inc.¹³
• Mar 15, 2022Shares withheld for tax 2,229 shares at $15.79 of Revance Therapeutics, Inc.¹⁴
• Mar 15, 2022Shares withheld for tax 2,881 shares at $15.79 of Revance Therapeutics, Inc.¹⁴
• Feb 2, 2022Granted 42,349 shares of Revance Therapeutics, Inc.¹⁰